BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6802647)

  • 1. Influence of ascites on the pharmacokinetics of hexamethylmelamine and N-demethylated metabolites in ovarian cancer patients.
    D'Incalci M; Beggiolin G; Sessa C; Mangioni C
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1331-5. PubMed ID: 6802647
    [No Abstract]   [Full Text] [Related]  

  • 2. Hexamethylmelamine distribution in patients with ovarian and other pelvic cancers.
    D'Incalci M; Farina P; Sessa C; Mangioni C; Garattini S
    Cancer Treat Rep; 1982 Feb; 66(2):231-5. PubMed ID: 6799199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.
    Garattini E; Donelli MG; Colombo T; Paesani R; Pantarotto C
    Biochem Pharmacol; 1981 May; 30(10):1151-4. PubMed ID: 6789835
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
    Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
    Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.
    Garattini E; Colombo T; Donelli MG; Catalani P; Bianchi M; D'Incalci M; Pantarotto C
    Cancer Chemother Pharmacol; 1983; 11(1):51-5. PubMed ID: 6411375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administration.
    Dubois J; Atassi G; Hanocq M; Abikhalil F
    Cancer Chemother Pharmacol; 1986; 18(3):226-30. PubMed ID: 3100080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
    Broggini M; Rossi C; Colombo T; D'Incalci M
    Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid levels of hexamethylmelamine and N-demethylated metabolites.
    D'Incalci M; Sessa C; Beggiolin G; Mangioni C
    Cancer Treat Rep; 1981; 65(3-4):350-1. PubMed ID: 6786739
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of PMM in the rat.
    Colombo T; Torti L; D'Incalci M
    Cancer Chemother Pharmacol; 1981; 5(3):201-3. PubMed ID: 6794923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexamethylmelamine tissue concentrations in pelvic cancer patients.
    D'Incalci M; Farina P; Sessa C; Erba E; Madonna R; Mangioni C
    Ther Drug Monit; 1980; 2(2):187-8. PubMed ID: 6820202
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo studies with hexamethylmelamine.
    Rutty CJ; Connors TA; Nguyen-Hoang-Nam ; Do-Cao-Thang ; Hoellinger H
    Eur J Cancer (1965); 1978 Jun; 14(6):713-20. PubMed ID: 95953
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.
    Begleiter A; Grover J; Goldenberg GJ
    Cancer Res; 1980 Dec; 40(12):4489-94. PubMed ID: 6777039
    [No Abstract]   [Full Text] [Related]  

  • 13. N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine.
    Gescher A; D'Incalci M; Fanelli R; Farina P
    Life Sci; 1980 Jan; 26(2):147-54. PubMed ID: 6767887
    [No Abstract]   [Full Text] [Related]  

  • 14. Variable oral absorption of hexamethylmelamine in man.
    D'Incalci M; Bolis G; Mangioni C; Morasca L; Garattini S
    Cancer Treat Rep; 1978 Dec; 62(12):2117-9. PubMed ID: 109196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.
    D'Incalci M; Erba E; Balconi G; Morasca L; Garattini S
    Br J Cancer; 1980 Apr; 41(4):630-5. PubMed ID: 6770884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
    Ames MM; Powis G; Kovach JS; Eagan RT
    Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamine.
    Brindley C; Gescher A; Langdon SP; Broggini M; Colombo T; D'Incalci M
    Biochem Pharmacol; 1982 Mar; 31(5):625-31. PubMed ID: 6805472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.
    Ames MM; Sanders ME; Tiede WS
    Life Sci; 1981 Oct; 29(15):1591-8. PubMed ID: 6795407
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid formation of N-hydroxymethylpentamethylmelamine by mitochondria from rat small intestinal epithelium.
    Borm P; Mingels MJ; Hulshoff A; Frankhuyzen-Sierevogel A; Noordhoek J
    Life Sci; 1983 Nov; 33(21):2113-9. PubMed ID: 6417431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids.
    Benvenuto JA; Stewart DJ; Benjamin RS; Smith RG; Loo TL
    J Chromatogr; 1981 Mar; 222(3):518-22. PubMed ID: 6785285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.